Catalyst Wire Dossier Catalyst Wire Dossier

GP40221

· Geropharm
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GP40221, covering 2024-07-11 to 2024-07-11. Get the full timeline:

Most recent: Clinical Trial Update: Open Randomized Study of Comparative Pharmacokinetics and Biosimilarity of GP40221 (GEROPHARM LLC, Russia) and Ozempic®. [Phase 1]

See pricing